Polish Validation of Psychedelic Attitudes Tools Among Psychology Students

Polish Tools for Measuring Attitudes Toward Psychedelics Validated

Researchers in Poland have validated Polish-language versions of two key instruments—the Attitudes toward Psychedelics Questionnaire (APQ) and the Evidence-Based Practice Attitude Scale (EBPAS-15)—for use among psychology students. The study, published on November 8, 2026, responds to the growing need for reliable, culturally-adapted tools to assess how future mental health professionals view psychedelic-assisted therapy (PAT) and evidence-based practice. This validation is a foundational step for research, education, and policy development as Poland and other countries consider the potential clinical integration of substances such as psilocybin, LSD, MDMA, and DMT.

Mechanism and Context: Why Psychometric Validation Matters

Psychometric validation ensures that survey instruments accurately and reliably measure the intended attitudes within a specific cultural and linguistic context. The APQ and EBPAS-15 are widely used in international research to gauge openness to psychedelics and commitment to evidence-based practice, but their translation and adaptation require rigorous testing to avoid misinterpretation or bias. In this study, Polish psychology students—the next generation of clinicians—completed the translated questionnaires online, allowing researchers to assess reliability, internal consistency, and theoretical validity.

Crucially, the study addresses a gap that has limited previous Polish research: earlier surveys used translated tools whose psychometric properties in Poland were untested, risking unreliable results. By formally validating these instruments, the researchers provide a robust foundation for future studies, enabling more accurate tracking of shifts in professional attitudes as policy debates and clinical trials progress.

Policy and Research Implications for Poland and Beyond

Validated measurement tools are a prerequisite for evidence-based workforce development, clinical training, and policy analysis. As legislative processes regarding psychedelics advance in Europe, North America, and Australia, understanding clinician and student attitudes becomes critical for anticipating barriers and opportunities in the adoption of PAT. In Poland, where clinical research on psychedelics is emerging but legal and social uncertainties persist, these validated instruments allow for systematic monitoring of how education, media, and policy changes may influence professional readiness and skepticism.

• Workforce Training: Universities and training programs can now reliably assess how students’ attitudes evolve in response to new curricula or public debates on psychedelics.
• Policy Development: Policymakers gain access to data on the readiness and concerns of future practitioners, informing regulatory and educational strategies.
• International Comparability: The validated Polish versions enable cross-country comparisons, revealing how cultural context shapes attitudes toward psychedelics and evidence-based practice.

One non-obvious implication is that reliable attitude measurement can identify subgroups of students—such as those more skeptical of evidence-based practice—who may require targeted education or support as the field evolves. This segmentation could help avoid workforce polarization as psychedelic therapies enter mainstream discourse.

Risks, Unknowns, and Limitations

Validated psychometric tools do not resolve underlying controversies about psychedelic therapy’s safety, efficacy, or social acceptability. The instruments measure attitudes, not clinical outcomes or legal compliance. Additionally, while psychology students represent future clinicians, their views may not reflect those of practicing professionals or the broader public. The study’s online, anonymous design enhances participation but may introduce selection bias.

Another limitation is that attitudes measured today may shift rapidly as new research, policy changes, or high-profile clinical events occur. The tools will require periodic revalidation to ensure continued relevance. Finally, the instruments’ focus on self-reported attitudes cannot capture the full complexity of professional decision-making in real-world clinical settings.

Looking Forward: Building Infrastructure for Psychedelic Research in Poland

The validation of the APQ and EBPAS-15 in Polish is a significant infrastructure advance for psychedelic research, workforce development, and policy analysis. As clinical trials and legislative debates accelerate, these tools will enable researchers and educators to track how attitudes evolve and to design interventions that address skepticism or misinformation. The next steps include applying these instruments in longitudinal studies, expanding validation to other professional groups, and integrating attitude measurement into clinical and educational pilot programs.

By investing in psychometric rigor now, Poland positions itself to respond nimbly to global developments in psychedelic policy and practice—ensuring that future clinical adoption, if it occurs, is informed by reliable data on the perspectives of those who will deliver care.

By Dr. Aleksandra Nowak, PhD (Clinical Psychology). How we research: This article was reviewed by Dr. Nowak on 2026-11-12, drawing on the original study and primary regulatory sources.